首页> 美国卫生研究院文献>The Primary Care Companion for CNS Disorders >A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques Risks and Regulations Associated With the Subversion of Urine Drug Tests
【2h】

A Case of Psychosis After Use of a Detoxification Kit and a Review of Techniques Risks and Regulations Associated With the Subversion of Urine Drug Tests

机译:使用排毒试剂盒后发生精神病的案例以及与颠覆尿液药物测试相关的技术风险和法规的回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Context: The practice of drug testing in the workplace has been adopted for US federal government employees, and many state and local governments as well as private businesses have followed suit. However, a parallel industry dedicated to subverting the results of urine drug testing has emerged with little or no regulation.>Evidence Acquisition: First, the case of a 19-year-old man who developed psychosis after the use of a detoxification kit is presented. Second, a review of the existing literature on the techniques, risks, and regulations associated with the use of drug tampering kits is provided. PubMed, Cochrane Database, and Google Scholar were searched using the keywords UDS, urine toxicology, pass the drug test, and clean UA, with no restrictions on publication date. Case reports, letters to the editor, and original research and review articles in multiple languages were reviewed, as were federal regulations and acts on the topic. The search yielded 4,082 results, of which 49 articles were selected for relevance. Some articles were later omitted as they had cited the original article and had nothing new to offer.>Results: Three commonly used tampering techniques are in vivo adulteration, urine substitution, and in vitro adulteration. Review of the literature regarding the risks involved with use of tampering kits yielded no results. In 1986, an executive order was issued requiring all federal employees to refrain from illicit drug use, and the 1988 Drug-Free Workplace Act precipitated the Substance Abuse and Mental Health Services Administration guidelines and their subsequent revisions. Recently, many states have made regulatory efforts to bring drug test defrauding under the ambit of law.>Conclusions: Clinicians need to be aware of the tampering techniques and the possibility of false-negative urine drug tests. Cognizance of inherent risks involved with using these techniques including psychiatric and/or medical complications is also warranted. The manufacture, sale, and use of these products have little or no regulation by state or federal authorities, making them potentially dangerous and imposing new challenges in testing for abused drugs. The extent of use of these products and techniques is not known at this time and is an area that warrants further research.
机译:>背景:美国联邦政府雇员采用了工作场所中的药物检测方法,许多州和地方政府以及私营企业也纷纷效仿。但是,出现了旨在颠覆尿液药物检测结果的并行行业,几乎没有或没有任何法规。>证据获取:首先,一名19岁男子在使用后出现精神病的案例介绍了排毒套件。其次,提供了有关与药物篡改套件的使用相关的技术,风险和法规的现有文献的综述。使用关键字UDS,尿毒理学,通过药物测试和清洁UA来搜索PubMed,Cochrane数据库和Google Scholar,并且没有发布日期的限制。审查了案例报告,致编辑的信以及多语言的原创研究和评论文章,以及有关该主题的联邦法规和法案。搜索产生了4,082个结果,其中有49篇相关文章被选中。一些文章后来由于引用了原始文章而没有提供新内容,因此被省略。>结果:三种常用的篡改技术是体内掺假,尿液替代和体外掺假。有关使用篡改工具包所涉及的风险的文献综述未得出任何结果。 1986年,发布了一项行政命令,要求所有联邦雇员不得使用非法药物,1988年的《无毒工作场所法》促成了《药物滥用和精神卫生服务管理指南》及其后续修订。最近,许多州已作出监管努力,将药物测试欺诈行为纳入法律的管辖范围。>结论:临床医生需要意识到篡改技术以及假阴性尿液药物测试的可能性。还必须意识到与使用这些技术有关的固有风险,包括精神疾病和/或医学并发症。这些产品的制造,销售和使用受到州或联邦当局的监管很少甚至没有,这使其具有潜在的危险,并在滥用药物的检测方面提出了新的挑战。目前尚不知道这些产品和技术的使用范围,这是一个值得进一步研究的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号